LV5514A3 -
Attenuation inhibits linkage to the acquisition of content-substituted diazabicycloalkylcholonecarbons or their pharmaceutically acceptable additive islands
- Google Patents
Attenuation inhibits linkage to the acquisition of content-substituted diazabicycloalkylcholonecarbons or their pharmaceutically acceptable additive islands
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from SU864028142Aexternal-prioritypatent/SU1482531A3/en
Application filed by PfizerfiledCriticalPfizer
Publication of LV5514A3publicationCriticalpatent/LV5514A3/en
LV931158A1985-09-181993-10-19
Attenuation inhibits linkage to the acquisition of content-substituted diazabicycloalkylcholonecarbons or their pharmaceutically acceptable additive islands
LV5514A3
(en)
Attenuation inhibits linkage to the acquisition of content-substituted diazabicycloalkylcholonecarbons or their pharmaceutically acceptable additive islands
Attenuation inhibits linkage to the acquisition of content-substituted diazabicycloalkylcholonecarbons or their pharmaceutically acceptable additive islands